Medullary ca of thyroid is associated with increase in –
Now, the question asks what is increased in MTC. The correct answer should be calcitonin. But since the options aren't here, I need to think about the distractors. Common options might include other hormones or markers. For example, maybe TSH, T3, T4, or something else. Alternatively, maybe CEA (carcinoembryonic antigen), which is a tumor marker for MTC. Wait, but the question is about an increase, so CEA is a marker but not the primary one. The primary marker is calcitonin.
Wait, but sometimes people confuse MTC with other thyroid cancers. For instance, follicular carcinoma might be associated with TSH or other markers. Medullary is unique in that it's C-cell origin. Also, MTC can be part of multiple endocrine neoplasia type 2 (MEN2), so maybe the options include other hormones from other glands, but the question is specifically about the thyroid. So the main point is calcitonin.
So, if the options were, say, A. Calcitonin, B. TSH, C. CEA, D. Thyroglobulin, then the correct answer is A. The distractors would be incorrect because TSH is decreased in hyperthyroidism, but MTC is a C-cell tumor, not follicular. CEA is a tumor marker but not the direct increase from the tumor itself. Thyroglobulin is a marker for follicular or papillary thyroid cancer, not medullary.
The core concept here is understanding the origin of MTC and its associated markers. The clinical pearl would be that calcitonin is the key marker for MTC, and CEA is used as a tumor marker for follow-up. So, even without the exact options, the correct answer is calcitonin. The user needs to structure the explanation accordingly, making sure to cover why calcitonin is correct and why other options like TSH, CEA, thyroglobulin are not.
**Core Concept**
Medullary thyroid carcinoma (MTC) originates from parafollicular C cells, which secrete **calcitonin**. This tumor is characterized by elevated serum calcitonin levels, distinguishing it from other thyroid cancers like follicular (thyroglobulin) or papillary (TSH receptor).
**Why the Correct Answer is Right**
In MTC, the neoplastic C cells overproduce **calcitonin**, a peptide hormone that lowers blood calcium. Diagnostic criteria for MTC include a markedly elevated baseline calcitonin level (>100 pg/mL). Additionally, MTC may be sporadic or part of **multiple endocrine neoplasia type 2 (MEN2)**, further linking it to calcitonin as a biomarker and therapeutic target.
**Why Each Wrong Option is Incorrect**
**Option A:** *TSH* is typically suppressed